a Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
b Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD
c Positron Emission Tomography Department, National Cancer Institute, National Institutes of Health, Bethesda, MD
d Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD
e Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
*Correspondence address: Samira M Sadowski, MD, Endocrine Oncology Branch, National Cancer Institute, NIH Clinical Research Center, Building 10-CRC, Room 3W-5840, Bethesda, MD 20892.
E-mail: [email protected]
Received August 27, 2013; revised January 1, 2014; accepted January 7, 2014.
Disclosure Information: Nothing to disclose.
Support: This research was supported by the intramural research program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health.
